The Joint Commission revises anticoagulant therapy national patient safety goal: 3 details

Written by Rachel Popa | February 14, 2019 | Print  |

The Joint Commission revised its national patient safety goal for anticoagulant therapy in ambulatory care settings.

The key details to know:

1. The revisions address patient and family education, patient monitoring, approved protocols and new practices for Heparin and Warfarin use.

2. The guidelines take effect July 1. and the goal doesn't apply to episodic and occupational health providers.

3. The new goal aims to help prevent adverse drug events.

Read more here.

More articles on accreditation:
Crater Lake Surgery Center earns AAAHC accreditation — 3 highlights
How HFAP's change of ownership affects accredited ASCs — 4 insights
The Joint Commission debuts infection prevention initiative

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.